Compras y ventas de directivos de Xylem (XYL)
Qué compran y venden los consejeros y directivos del S&P 500 en sus propias empresas, tal cual lo presentan en los Formularios 4 de la SEC (2 días hábiles de plazo): cada fila con su código oficial y sin filtrar nada.
Las compras en mercado abierto (código P) son la señal rara, en verde; las ventas (código S) son frecuentes y muchas van programadas (10b5-1). La tabla II (derivados) no se incluye: sus precios son de ejercicio, no de mercado. Guía: compras de directivos.
| Fecha | Ticker | Directivo | Cargo | Acciones | Precio | Importe | % posición | Tipo / documento |
|---|
Descargar estas transacciones en CSV Sin cuenta y sin registro. Los datos son públicos: salen de los Formularios 4 de la SEC.
Compras y ventas de directivos de Xylem Inc. (XYL): 1 compra y 4 ventas
58 transacciones de la tabla I del Formulario 4 declaradas ante la SEC por directivos de Xylem Inc. entre el 2025-09-03 y el 2026-10-01 (histórico de 15 meses): 1 compra y 4 ventas en mercado abierto, y 53 transacciones con otros códigos del Formulario 4, desglosados uno a uno más abajo. La mayor operación en mercado abierto es una venta de $1,6M de Toussaint Claudia S el 2025-10-30.
Compras y ventas de directivos de Xylem en los últimos 12 meses
Entre el 21 oct 2025 y el 20 oct 2026, los directivos de Xylem declararon 1 compra por $141k y 3 ventas por $2,3M en mercado abierto. El saldo neto es vendedor: salen $2,2M más de los que entran.
Quien más compró fue Peribere Jerome A (Consejero): $141k en 1 compra, el único comprador. Quien más vendió fue Toussaint Claudia S (EVP, CPSO): $1,6M en 1 venta, de 3 vendedores distintos.
La mayor operación del período fue una venta de $1,6M el 30 oct 2025, de Toussaint Claudia S (EVP, CPSO). Formulario 4 en sec.gov (0001524472-25-000050).
Ninguna de las 3 ventas lleva en el Formulario 4 la marca de plan 10b5-1 (las ventas programadas con meses de antelación).
En los tres últimos meses hay 0 compras y 0 ventas, frente a 1 y 1 en los tres anteriores. La última compra es del 4 may 2026; la última venta, del 7 may 2026.
Frente a su sector (Industria, 75 empresas con página de directivos en esta web), en las mismas fechas la mediana es de 8 ventas y 0 compras en mercado abierto. Xylem tiene más ventas que 11 de las otras 74, es la 64.ª de 75 por dinero neto vendido, y 28 de las 75 tienen al menos una compra, Xylem incluida.
Las 20 operaciones más importantes
Primero la única compra en mercado abierto y después el resto, cada tipo de mayor a menor importe. El histórico completo está en la herramienta de arriba, ya buscado.
Ver las 58 operaciones de XYL en el histórico completo →
| Operación | Declarada | Directivo | Cargo | Importe | Código | Documento |
|---|---|---|---|---|---|---|
| 2026-05-04 | 2026-05-04 | Peribere Jerome A | Consejero | $141k | P — Compra en mercado abierto Tenencia indirecta, a través de: Jerome A Peribere 2016 Revocable TR | SEC |
| 2025-10-30 | 2025-10-31 | Toussaint Claudia S | EVP, CPSO | $1,6M | S — Venta en mercado abierto Tenencia indirecta, a través de: by Claudia S. Toussaint Revocable Trust 2 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the sale of shares of common stock from the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust. F2 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 10,421 Shares were executed at a range of prices from $152.51 to $152.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. | SEC |
| 2026-05-07 | 2026-05-08 | Mcshane Geri-Michelle | SVP, CAO | $501k | S — Venta en mercado abiertoNota del Formulario 4 (texto original de la SEC, en inglés)F1 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,269 Shares were executed at a range of prices from $117.42 to $118.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. | SEC |
| 2025-11-04 | 2025-11-05 | Harker Victoria D | Consejero | $252k | S — Venta en mercado abiertoNota del Formulario 4 (texto original de la SEC, en inglés)F1 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,700 Shares were executed at a range of prices from $148.135 to $148.135. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. | SEC |
| 2025-09-05 | 2025-09-05 | Mcshane Geri-Michelle | VP, CAO | $140k | S — Venta en mercado abiertoNota del Formulario 4 (texto original de la SEC, en inglés)F1 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,000 Shares were executed at a range of prices from $139.96 to $139.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. | SEC |
| 2026-03-01 | 2026-03-03 | Pine Matthew Francis | Pres. & CEO | $1,9M | A — Adjudicación o premio de acciones5 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 5,243 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Includes additional shares due to dividend reinvestment. F3 Reflects the acquisition of 4,328 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F4 Reflects the acquisition of 2,943 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. F5 Reflects the acquisition of 2,152 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. | SEC |
| 2026-03-01 | 2026-03-03 | Grogan William K | EVP & Chief Financial Officer | $1,7M | A — Adjudicación o premio de acciones4 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 5,551 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Includes additional shares due to dividend reinvestment. F3 Reflects the acquisition of 4,583 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F4 Reflects the acquisition of 3,117 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. | SEC |
| 2026-03-01 | 2026-03-03 | Yarkadas Hayati | EVP & President, WI | $1,6M | A — Adjudicación o premio de acciones5 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 4,456 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Includes additional shares due to dividend reinvestment. F3 Reflects the acquisition of 3,679 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F4 Reflects the acquisition of 2,501 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. F5 Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. | SEC |
| 2026-03-02 | 2026-03-03 | Pine Matthew Francis | Pres. & CEO | $1,0M | F — Retención fiscal (acciones entregadas por impuestos)3 notas del Formulario 4 (texto original de la SEC, en inglés)F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). F8 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). F9 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (649) and March 1, 2024 (1,667) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). | SEC |
| 2026-03-01 | 2026-03-03 | Toussaint Claudia S | EVP, CPSO | $954k | A — Adjudicación o premio de acciones4 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 2,360 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Reflects the acquisition of 1,948 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F3 Reflects the acquisition of 1,324 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. F4 Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. | SEC |
| 2026-03-02 | 2026-03-03 | Grogan William K | EVP & Chief Financial Officer | $834k | F — Retención fiscal (acciones entregadas por impuestos)2 notas del Formulario 4 (texto original de la SEC, en inglés)F6 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (578) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). | SEC |
| 2026-03-01 | 2026-03-03 | Mcgann Michael J. | EVP & President, MCS | $668k | A — Adjudicación o premio de acciones5 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 1,966 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Includes additional shares due to dividend reinvestment. F3 Reflects the acquisition of 1,622 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F4 Reflects the acquisition of 1,103 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. F5 Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. | SEC |
| 2025-09-18 | 2025-09-18 | Grogan William K | SVP & Chief Financial Officer | $605k | F — Retención fiscal (acciones entregadas por impuestos)2 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on September 18, 2023 (4,254) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). F2 Includes additional shares due to dividend reinvestment. | SEC |
| 2026-03-02 | 2026-03-03 | Toussaint Claudia S | EVP, CPSO | $513k | F — Retención fiscal (acciones entregadas por impuestos)3 notas del Formulario 4 (texto original de la SEC, en inglés)F6 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). F8 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (336) and March 1, 2024 (266) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). | SEC |
| 2026-03-01 | 2026-03-03 | Cho Albert | EVP, Strategy | $479k | A — Adjudicación o premio de acciones5 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 1,311 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Includes additional shares due to dividend reinvestment. F3 Reflects the acquisition of 1,082 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F4 Reflects the acquisition of 735 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. F5 Reflects the acquisition of 587 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. | SEC |
| 2026-03-02 | 2026-03-03 | Mcgann Michael J. | EVP & President, MCS | $361k | F — Retención fiscal (acciones entregadas por impuestos)3 notas del Formulario 4 (texto original de la SEC, en inglés)F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). F8 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). F9 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (269) and March 1, 2024 (241) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). | SEC |
| 2026-03-02 | 2026-03-03 | Cho Albert | EVP, Strategy | $294k | F — Retención fiscal (acciones entregadas por impuestos)3 notas del Formulario 4 (texto original de la SEC, en inglés)F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). F8 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). F9 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (207) and March 1, 2024 (164) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). | SEC |
| 2026-05-14 | 2026-05-15 | Friel Robert F | Consejero | $290k | A — Adjudicación o premio de acciones2 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. F2 Includes additional shares due to dividend reinvestment. | SEC |
| 2026-03-01 | 2026-03-03 | Mcshane Geri-Michelle | SVP, CAO | $285k | A — Adjudicación o premio de acciones4 notas del Formulario 4 (texto original de la SEC, en inglés)F1 Reflects the acquisition of 721 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 Reflects the acquisition of 595 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. F3 Reflects the acquisition of 405 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. F4 Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. | SEC |
| 2026-05-07 | 2026-05-08 | Mcshane Geri-Michelle | SVP, CAO | $273k | M — Ejercicio de opciones | SEC |
El saldo del período: cuánto dinero entra y cuánto sale
En los Formularios 4 presentados entre el 3 sept 2025 y el 1 oct 2026, el mercado abierto de Xylem Inc. suma 1 compra por $141k y 4 ventas por $2,5M. El saldo es de $2,3M a favor de las ventas.
Solo cuentan los códigos P y S, donde el directivo pone o saca su propio dinero. Que el saldo de Xylem Inc. salga vendedor es lo habitual en el S&P 500, donde buena parte del sueldo se cobra en acciones. No es una recomendación de comprar ni de vender: es lo que se declaró.
Todas las transacciones, código por código
| Código | Qué significa | Operaciones | Importe declarado |
|---|---|---|---|
| A | Adjudicación o premio de acciones | 30 | $9,5M |
| F | Retención fiscal (acciones entregadas por impuestos) | 22 | $4,8M |
| S | Venta en mercado abierto | 4 | $2,5M |
| M | Ejercicio de opciones | 1 | $273k |
| P | Compra en mercado abierto | 1 | $141k |
| Total | Todo lo declarado en el período | 58 | $17,3M |
13 de las 58 filas no traen un importe utilizable en el Formulario 4: cuentan como operación y suman $0. Las etiquetas son las del índice de códigos de la SEC.
Quién ha operado
En los 15 meses del histórico han declarado operaciones de Xylem Inc. 21 personas o entidades distintas. De ellas, 1 compró en mercado abierto y 3 vendieron. Se cuentan por su CIK, el número fijo que la SEC da a cada declarante, y no por el nombre, que cada uno escribe a su manera.
| Declarante | Cargo | Transacciones | Comprado (nº) | Vendido (nº) | Última declarada |
|---|---|---|---|---|---|
| Toussaint Claudia S | EVP, CP&SO | 5 | — | $1,6M (1) | 2026-03-06 |
| Mcshane Geri-Michelle | SVP, CAO | 8 | — | $641k (2) | 2026-10-01 |
| Harker Victoria D | Consejero | 2 | — | $252k (1) | 2026-05-15 |
| Peribere Jerome A | Consejero | 2 | $141k (1) | — | 2026-05-15 |
| Aulick Rodney | EVP & President, WSS | 5 | — | — | 2026-03-06 |
| Grogan William K | EVP & Chief Financial Officer | 5 | — | — | 2026-03-06 |
| Cho Albert | EVP, Strategy | 4 | — | — | 2026-03-06 |
| Mcgann Michael J. | EVP & President, MCS | 4 | — | — | 2026-03-06 |
Se enseñan los 8 que más dinero movieron, de 21. Los demás están en el histórico completo, que se abre con el enlace de arriba. El nombre lleva a todas sus operaciones, en cualquier empresa. «Transacciones» cuenta cualquier código; el dinero, solo mercado abierto. Cargo: el de su última declaración.
Mes a mes
Por el mes en que se operó, no en el que se presentó el formulario; los meses sin operaciones van a cero. El mes con más movimiento fue may 2026: 1 compra y 1 venta, por $643k. 11 de los 15 meses no tienen ninguna.
| Mes | Compras | Importe | Ventas | Importe |
|---|---|---|---|---|
| ago 2025 | 0 | $0 | 0 | $0 |
| sept 2025 | 0 | $0 | 1 | $140k |
| oct 2025 | 0 | $0 | 1 | $1,6M |
| nov 2025 | 0 | $0 | 1 | $252k |
| dic 2025 | 0 | $0 | 0 | $0 |
| ene 2026 | 0 | $0 | 0 | $0 |
| feb 2026 | 0 | $0 | 0 | $0 |
| mar 2026 | 0 | $0 | 0 | $0 |
| abr 2026 | 0 | $0 | 0 | $0 |
| may 2026 | 1 | $141k | 1 | $501k |
| jun 2026 | 0 | $0 | 0 | $0 |
| jul 2026 | 0 | $0 | 0 | $0 |
| ago 2026 | 0 | $0 | 0 | $0 |
| sept 2026 | 0 | $0 | 0 | $0 |
| oct 2026 | 0 | $0 | 0 | $0 |
El último mes puede ir incompleto: el Formulario 4 se presenta hasta dos días hábiles después. La tabla no dice si el patrón es bueno o malo; dice cuándo pasó.
Ficha de análisis de Xylem Inc. (XYL) →
Otras empresas de Industria con operaciones de directivos
Están las 500 en el índice de la sección →
Qué directivos están comprando acciones de su propia empresa →
Cómo leer estos datos
Ninguna de las 4 ventas de la tabla va marcada como programada (plan 10b5-1), la venta que se firma con meses de antelación y se ejecuta sola. La única compra en mercado abierto (código P) de Xylem es la señal rara: los directivos ya cobran en acciones, y comprar más es poner dinero propio. La última presentación es del 1 oct 2026, y el Formulario 4 llega hasta dos días hábiles después de operar.
18 de las 20 filas de la tabla llevan notas al pie del propio Formulario 4, plegadas en la columna del código y copiadas tal cual, en inglés; una fila sin nota es que el formulario no la trae.
Guía: Compras de directivos · todas las guías
Lo que hay detrás de estas operaciones
Los conceptos de esta página, explicados desde cero en la Academia. Gratis y sin cuenta.
- Qué dice y qué NO dice la hipótesis de eficienciaSi la compra de un directivo es pública y cualquiera puede leerla, ¿queda información dentro? Es la pregunta exacta que trae a esta página.
- Quién mueve realmente el mercado: los tipos de inversoresQuién hay al otro lado de cada orden, y qué sitio ocupan entre ellos los directivos de la propia empresa.
- Oferta, demanda y el precio: por qué sube y baja constantementeCómo acaba una noticia metida en el precio, y por qué la reacción a una venta declarada rara vez es la que uno esperaría.
Fuente: SEC EDGAR Formulario 4. Esto es una lista de hechos públicos, no asesoramiento financiero ni una recomendación de compra o venta.